Newmont Corporation vs Vertex Pharmaceuticals Incorporated
Market cap comparison over time
Newmont Corporation
$127.9B
Rank #127
Vertex Pharmaceuticals Incorporated
$133.4B
Rank #123
Market Cap Over Time
Key Moments
- Vertex Pharmaceuticals Incorporated overtook Newmont Corporation by 2000
- Newmont Corporation overtook Vertex Pharmaceuticals Incorporated by 2001
- Vertex Pharmaceuticals Incorporated overtook Newmont Corporation by 2013
- Newmont Corporation overtook Vertex Pharmaceuticals Incorporated by 2016
- Vertex Pharmaceuticals Incorporated overtook Newmont Corporation by 2017
- Newmont Corporation overtook Vertex Pharmaceuticals Incorporated by 2021
- Vertex Pharmaceuticals Incorporated overtook Newmont Corporation by 2022
Year-by-Year Comparison
| Year | Newmont Corporation | Vertex Pharmaceuticals Incorporated | Leader |
|---|---|---|---|
| 2026 | $127.9B | $133.4B | Vertex Pharmaceuticals Incorporated |
| 2025 | $106.1B | $115.1B | Vertex Pharmaceuticals Incorporated |
| 2024 | $38.9B | $102.2B | Vertex Pharmaceuticals Incorporated |
| 2023 | $42.2B | $103.3B | Vertex Pharmaceuticals Incorporated |
| 2022 | $45.7B | $73.3B | Vertex Pharmaceuticals Incorporated |
| 2021 | $57.8B | $55.7B | Newmont Corporation |
| 2020 | $54.0B | $60.0B | Vertex Pharmaceuticals Incorporated |
| 2019 | $38.6B | $55.6B | Vertex Pharmaceuticals Incorporated |
| 2018 | $29.6B | $42.1B | Vertex Pharmaceuticals Incorporated |
| 2017 | $31.6B | $38.0B | Vertex Pharmaceuticals Incorporated |
| 2016 | $28.5B | $18.7B | Newmont Corporation |
| 2015 | $15.0B | $31.9B | Vertex Pharmaceuticals Incorporated |
| 2014 | $15.7B | $30.2B | Vertex Pharmaceuticals Incorporated |
| 2013 | $18.8B | $18.9B | Vertex Pharmaceuticals Incorporated |
| 2012 | $36.5B | $10.6B | Newmont Corporation |
| 2011 | $46.0B | $8.4B | Newmont Corporation |
| 2010 | $46.4B | $8.9B | Newmont Corporation |
| 2009 | $35.5B | $10.9B | Newmont Corporation |
| 2008 | $30.2B | $7.7B | Newmont Corporation |
| 2007 | $35.9B | $5.9B | Newmont Corporation |
| 2006 | $32.9B | $9.5B | Newmont Corporation |
| 2005 | $38.7B | $7.0B | Newmont Corporation |
| 2004 | $31.9B | $2.7B | Newmont Corporation |
| 2003 | $34.6B | $2.6B | Newmont Corporation |
| 2002 | $20.6B | $4.0B | Newmont Corporation |
| 2001 | $13.5B | $6.2B | Newmont Corporation |
| 2000 | $12.0B | $18.1B | Vertex Pharmaceuticals Incorporated |
| 1999 | $17.1B | $4.4B | Newmont Corporation |
| 1998 | $12.6B | $3.8B | Newmont Corporation |
| 1997 | $20.2B | $4.2B | Newmont Corporation |
| 1996 | $30.5B | $5.1B | Newmont Corporation |
| 1995 | $30.7B | $3.4B | Newmont Corporation |
| 1994 | $24.1B | $1.9B | Newmont Corporation |